Life science tools Q3 preview: Barclays ups Charles River, downgrades Medpace

Go back to Life science tools Q3 preview: Barclays ups Charles River, downgrades Medpace
CHARLES RIVER LABORATORIE (NYSE: CRL) Delayed: 199.95 +13.35 (7.15%)
Previous Close $186.60    52 Week High $89.18 
Open $189.91    52 Week Low $65.70 
Day High $202.36    P/E 93.00 
Day Low $189.91    EPS $2.15 
Volume 391,069       

Danaher Corp. (NYSE: DHR) Delayed: 187.97 +9.00 (5.03%)
Previous Close $178.97    52 Week High $102.79 
Open $181.06    52 Week Low $75.71 
Day High $188.86    P/E 49.47 
Day Low $179.93    EPS $3.80 
Volume 2,260,532       

ICON (NASDAQ: ICLR) Delayed: 159.59 +16.92 (11.86%)
Previous Close $142.67    52 Week High $85.74 
Open $147.79    52 Week Low $62.31 
Day High $160.91    P/E N/A 
Day Low $147.71    EPS $0.00 
Volume 1,016,670       

Medspas of America, Inc. New (NASDAQ: MEDP) Delayed: 507.79 +34.31 (7.25%)
Previous Close $473.48    52 Week High $35.58 
Open $479.00    52 Week Low $26.54 
Day High $509.15    P/E N/A 
Day Low $479.00    EPS $0.00 
Volume 191,891       

Thermo Fisher Scientific (NYSE: TMO) Delayed: 489.18 +19.83 (4.22%)
Previous Close $469.35    52 Week High $160.68 
Open $478.12    52 Week Low $119.75 
Day High $493.00    P/E 139.77 
Day Low $473.50    EPS $3.50 
Volume 680,680